Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Explore key trends in AI-driven discovery, biopharma manufacturing, and regulatory approvals shaping drug development success in 2026.
Navigating 2026 Pharma Challenges: Key Outcomes for Drug Development and Regulatory Pros
By healthadmin
Explore 2026 biopharma trends, AI in drug discovery, FDA approvals, and manufacturing innovations for pharmacologists and regulatory pros.
Indian drugmaker Aurobindo will need to divest four drugs from its proposed $250 million deal…
Pfizer is looking for a new CFO as Denton prepares to hang up his gloves and say goodbye to the drug company
By healthadmin
Four years after he joined the New York drugmaker’s ranks in the wake of the…
What is Novo Nordisk’s secret weapon to turn the tide against Eli Lilly and win…
In the latest development in the Zepzelka saga, Jazz and Pharmamar’s lung cancer drug fails phase 3 trial
By healthadmin
Early approval of Jazz Pharmaceuticals’ small cell lung cancer (SCLC) drug Zepzerka may be in…
Fierce Pharma Asia — Astellas Pharma CEO’s five-year plan. Takeda’s psoriasis victory. RA’s China Bridge Program
By healthadmin
Astellas Pharma’s CEO briefed Fiers on the company’s new five-year plan. Takeda’s candidate wins direct…
Astellas Pharma is staring down a $6 billion patent cliff for its prostate cancer treatment…
As cybersecurity threats have proliferated across industries in recent years, biopharmaceutical companies have emerged as…
Last year, Johnson & Johnson was a late entrant, announcing Imavi as the third FcRn…